Yale Jen
Stock Analyst at Laidlaw & Co.
(0.05)
# 4,251
Out of 4,876 analysts
15
Total ratings
14.29%
Success rate
-44.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yale Jen
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SNTI Senti Biosciences | Initiates: Buy | $5 | $2.12 | +135.85% | 1 | Jun 6, 2025 | |
ICAD iCAD, Inc. | Downgrades: Hold | n/a | $3.86 | - | 1 | Apr 17, 2025 | |
SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $84.02 | +24.97% | 2 | Mar 27, 2025 | |
NVCT Nuvectis Pharma | Initiates: Buy | $19 | $7.75 | +145.16% | 1 | Mar 17, 2025 | |
LFWD Lifeward | Initiates: Buy | $10 | $0.58 | +1,618.80% | 1 | Feb 10, 2025 | |
ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $7.18 | +568.52% | 1 | Jul 29, 2024 | |
MEIP MEI Pharma | Downgrades: Hold | n/a | $2.63 | - | 1 | Jul 23, 2024 | |
PHGE BiomX | Initiates: Buy | $25 | $0.45 | +5,455.56% | 1 | May 28, 2024 | |
INAB IN8bio | Initiates: Buy | $225 | $2.16 | +10,316.67% | 1 | Mar 18, 2024 | |
CING Cingulate | Downgrades: Hold | n/a | $4.10 | - | 2 | Dec 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.63 | +1,483.78% | 1 | Aug 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.85 | - | 1 | Aug 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $2.54 | +9,348.82% | 1 | Sep 6, 2022 |
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $2.12
Upside: +135.85%
iCAD, Inc.
Apr 17, 2025
Downgrades: Hold
Price Target: n/a
Current: $3.86
Upside: -
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $84.02
Upside: +24.97%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $7.75
Upside: +145.16%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.58
Upside: +1,618.80%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $7.18
Upside: +568.52%
MEI Pharma
Jul 23, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.63
Upside: -
BiomX
May 28, 2024
Initiates: Buy
Price Target: $25
Current: $0.45
Upside: +5,455.56%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $2.16
Upside: +10,316.67%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.10
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.63
Upside: +1,483.78%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.85
Upside: -
Sep 6, 2022
Initiates: Buy
Price Target: $240
Current: $2.54
Upside: +9,348.82%